ENTURIA, a medical company dedicated to preventative healthcare, is highlighting ChloraPrep – a cutaneous antisepsis system designed to prevent infections associated with invasive procedures.
Cutaneous antisepsis for invasive procedures
ChloraPrep contains 2% chlorhexidine gluconate and 70% isopropyl alcohol delivered to the skin through a range of innovative, sterile, single patient use applicators. The company claims that ChloraPrep is the only product licensed for cutaneous antisepsis, which allows healthcare professionals to comply with epic2: National Evidence-Based Guidelines for Preventing Healthcare Associated Infections.
